Progyny, Inc. Operating Expenses
Progyny, Inc. (PGNY) reported Operating Expenses of $49.30 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-07
- Progyny, Inc. operating expenses for the quarter ending 2026-06-30 was $49.30M, a 9.74% decline year-over-year.
- Progyny, Inc. operating expenses for the quarter ending 2026-03-31 was $47.69M, a 7.62% decline year-over-year.
- Progyny, Inc. operating expenses for the quarter ending 2025-12-31 was $61.66M, a 29.41% increase year-over-year.
- Progyny, Inc. operating expenses for the quarter ending 2025-09-30 was $51.31M, a 9.67% increase year-over-year.
- Progyny, Inc. operating expenses for fiscal 2025 was $219.21M, a 17.91% increase from fiscal 2024.
- Progyny, Inc. operating expenses for fiscal 2024 was $185.91M, a 5.26% increase from fiscal 2023.
- Progyny, Inc. operating expenses for fiscal 2023 was $176.62M, a 22.66% increase from fiscal 2022.
- Progyny, Inc. operating expenses for fiscal 2022 was $143.98M, a 80.44% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $49.30M 10-Q · filed 2026-08-07 | $96.99M 10-Q · filed 2026-08-07 | $158.65M derived: sum of 3 quarters · filed 2026-08-07 | $209.96M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2026-03-31 | $47.69M 10-Q · filed 2026-05-08 | $109.35M derived: sum of 2 quarters · filed 2026-05-08 | $160.66M derived: sum of 3 quarters · filed 2026-05-08 | $215.27M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-12-31 | $61.66M 10-K · filed 2026-02-27 | $112.97M derived: sum of 2 quarters · filed 2026-02-27 | $167.58M derived: sum of 3 quarters · filed 2026-08-07 | $219.21M 10-K · filed 2026-02-27 | |||
| 2025-09-30 | $51.31M 10-K · filed 2026-02-27 | $105.92M derived: sum of 2 quarters · filed 2026-08-07 | $157.55M 10-Q · filed 2025-11-07 | $205.19M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-06-30 | $54.62M 10-Q · filed 2026-08-07 | $106.24M 10-Q · filed 2026-08-07 | $153.88M derived: sum of 3 quarters · filed 2026-08-07 | $200.67M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-03-31 | $51.63M 10-Q · filed 2026-05-08 | $99.27M derived: sum of 2 quarters · filed 2026-05-08 | $146.06M derived: sum of 3 quarters · filed 2026-05-08 | $193.65M derived: sum of 4 quarters · filed 2026-05-08 | |||
| 2024-12-31 | $47.65M 10-K · filed 2026-02-27 | $94.43M derived: sum of 2 quarters · filed 2026-02-27 | $142.03M derived: sum of 3 quarters · filed 2026-02-27 | $185.91M 10-K · filed 2026-02-27 | |||
| 2024-09-30 | $46.79M 10-K · filed 2026-02-27 | $94.38M derived: sum of 2 quarters · filed 2026-02-27 | $138.26M 10-Q · filed 2025-11-07 | $181.36M derived: sum of 4 quarters · filed 2026-02-27 | |||
| 2024-06-30 | $47.59M 10-K · filed 2026-02-27 | $91.48M 10-Q · filed 2025-08-08 | $134.57M derived: sum of 3 quarters · filed 2026-02-27 | $179.01M derived: sum of 4 quarters · filed 2026-02-27 | |||
| 2024-03-31 | $43.88M 10-K · filed 2026-02-27 | $86.98M derived: sum of 2 quarters · filed 2026-02-27 | $131.41M derived: sum of 3 quarters · filed 2026-02-27 | $176.87M derived: sum of 4 quarters · filed 2026-02-27 | |||
| 2023-12-31 | $43.09M 10-K · filed 2025-03-03 | $87.53M derived: sum of 2 quarters · filed 2025-03-03 | $132.99M derived: sum of 3 quarters · filed 2025-03-03 | $176.62M 10-K · filed 2026-02-27 | |||
| 2023-09-30 | $44.44M 10-K · filed 2025-03-03 | $89.89M derived: sum of 2 quarters · filed 2025-03-03 | $133.52M 10-Q · filed 2024-11-12 | $174.71M derived: sum of 4 quarters · filed 2025-03-03 | |||
| 2023-06-30 | $45.46M 10-K · filed 2025-03-03 | $89.09M 10-Q · filed 2024-08-07 | $130.27M derived: sum of 3 quarters · filed 2025-03-03 | $165.01M derived: sum of 4 quarters · filed 2025-03-03 | |||
| 2023-03-31 | $43.63M 10-K · filed 2025-03-03 | $84.82M derived: sum of 2 quarters · filed 2025-03-03 | $119.56M derived: sum of 3 quarters · filed 2025-03-03 | $154.61M derived: sum of 4 quarters · filed 2025-03-03 | |||
| 2022-12-31 | $41.19M 10-K · filed 2024-02-29 | $75.93M derived: sum of 2 quarters · filed 2024-02-29 | $110.98M derived: sum of 3 quarters · filed 2024-02-29 | $143.98M 10-K · filed 2025-03-03 | |||
| 2022-09-30 | $34.74M 10-K · filed 2024-02-29 | $69.79M derived: sum of 2 quarters · filed 2024-02-29 | $102.80M 10-Q · filed 2023-11-08 | $128.10M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-06-30 | $35.05M 10-K · filed 2024-02-29 | $68.06M 10-Q · filed 2023-08-04 | $93.36M derived: sum of 3 quarters · filed 2024-02-29 | $112.79M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-03-31 | $33.01M 10-K · filed 2024-02-29 | $58.31M derived: sum of 2 quarters · filed 2024-02-29 | $77.74M derived: sum of 3 quarters · filed 2024-02-29 | $95.70M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2021-12-31 | $25.30M 10-K · filed 2023-03-01 | $44.73M derived: sum of 2 quarters · filed 2023-03-01 | $62.70M derived: sum of 3 quarters · filed 2023-03-01 | $79.80M 10-K · filed 2024-02-29 | |||
| 2021-09-30 | $19.43M 10-K · filed 2023-03-01 | $37.39M derived: sum of 2 quarters · filed 2023-03-01 | $54.49M 10-Q · filed 2022-11-04 | $74.00M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-06-30 | $17.96M 10-K · filed 2023-03-01 | $35.06M 10-Q · filed 2022-08-05 | $54.57M derived: sum of 3 quarters · filed 2023-03-01 | $70.58M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-03-31 | $17.10M 10-K · filed 2023-03-01 | $36.60M derived: sum of 2 quarters · filed 2023-03-01 | $52.61M derived: sum of 3 quarters · filed 2023-03-01 | $65.64M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2020-12-31 | $19.50M 10-K · filed 2022-03-01 | $35.51M derived: sum of 2 quarters · filed 2022-03-01 | $48.54M derived: sum of 3 quarters · filed 2022-03-01 | $61.71M 10-K · filed 2023-03-01 | |||
| 2020-09-30 | $16.01M 10-K · filed 2022-03-01 | $15.47M 10-Q · filed 2020-11-06 | $29.04M derived: sum of 2 quarters · filed 2022-03-01 | $42.21M 10-Q · filed 2021-11-08 | $41.99M 10-Q · filed 2020-11-06 | $52.83M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | $13.03M 10-K · filed 2022-03-01 | $13.78M 10-Q · filed 2020-08-07 | $26.20M 10-Q · filed 2021-08-06 | $26.52M 10-Q · filed 2020-08-07 | $36.82M derived: sum of 3 quarters · filed 2022-03-01 | $46.07M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | $13.17M 10-K · filed 2022-03-01 | $12.74M 10-Q · filed 2020-05-14 | $23.80M derived: sum of 2 quarters · filed 2022-03-01 | $33.05M derived: sum of 3 quarters · filed 2022-03-01 | $42.15M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2019-12-31 | $10.63M 10-K · filed 2021-03-01 | $19.88M derived: sum of 2 quarters · filed 2021-03-01 | $28.97M derived: sum of 3 quarters · filed 2021-03-01 | $35.83M 10-K · filed 2022-03-01 | |||
| 2019-09-30 | $9.25M 10-K · filed 2021-03-01 | $18.35M derived: sum of 2 quarters · filed 2021-03-01 | $25.20M 10-Q · filed 2020-11-06 | $31.32M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-06-30 | $9.10M 10-K · filed 2021-03-01 | $15.95M 10-Q · filed 2020-08-07 | $22.07M derived: sum of 3 quarters · filed 2021-03-01 | $27.70M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-03-31 | $6.85M 10-K · filed 2021-03-01 | $12.97M derived: sum of 2 quarters · filed 2021-03-01 | $18.61M derived: sum of 3 quarters · filed 2021-03-01 | $23.96M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2018-12-31 | $6.12M 10-K · filed 2020-03-10 | $11.75M derived: sum of 2 quarters · filed 2020-03-10 | $17.11M derived: sum of 3 quarters · filed 2020-03-10 | $22.89M 10-K · filed 2021-03-01 | |||
| 2018-09-30 | $5.63M 10-K · filed 2020-03-10 | $10.99M derived: sum of 2 quarters · filed 2020-03-10 | $16.77M 10-Q · filed 2019-12-06 | ||||
| 2018-06-30 | $5.36M 10-K · filed 2020-03-10 | $11.13M derived: sum of 2 quarters · filed 2020-03-10 | |||||
| 2018-03-31 | $5.78M 10-K · filed 2020-03-10 | ||||||
| 2017-12-31 | $18.41M 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |